Perlmutter Cancer Center

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Acute Lymphoblastic Leukaemia [all]
• Age: Between 36 years - 1 years
• Gender: Male or Female

• Other Inclusion Criteria:
  

  1. Infants less than 1 year of age on the date of diagnosis are eligible; infants must be >36 weeks gestational age at the time of enrollment. 2. Patients must have newly diagnosed B lymphoblastic leukemia (also termed B-precursor acute lymphoblastic leukemia) or acute leukemia of ambiguous lineage (ALUL), which includes mixed phenotype acute leukemia (MPAL). 3. CNS status must be determined based on a sample obtained prior to the administration of any systemic or intrathecal chemotherapy
  

You may not be eligible for this study if the following are true:

• 1.Patients with known absence of KMT2A-Rearrangement leukemia prior to enrollment. 2. Patients with Down syndrome. 3. Patients with secondary B-ALL that developed after treatment of a prior malignancy with cytotoxic chemotherapy.